The first half of 2022 has brought noteworthy medical advances in breast and lung cancers, CRISPR gene editing, and new drugs were approved for genetic heart disease and diabetes.
The second half of the year could bring positive results from clinical trials for Alzheimer’s disease, cancer, and vision loss.
Click here to read the entire article to see 10 clinical trials to watch.